MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.radonc.2026.111696

Медицинская библиотека · Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2026

Medial retropharyngeal lymph node involvement in nasopharyngeal cancer patients treated with radiotherapy in Germany - A multicenter analysis.

Kaufmann Justus, Nikolaidou Eirini, Krabbes Isabel, Oji Nwabata, Ferdinandus Simone, Hlouschek Julian, Wurschi Georg, Becker Jan-Niklas, Schaule Jana, Müller Jörg-Andreas, Oebel Laura, Altmann Sebastian, Ehret Felix, Rühle Alexander, Grad Christian

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

PURPOSE/

OBJECTIVE

Prospective studies have demonstrated that involvement of medial retropharyngeal lymph nodes (MRLN) in endemic nasopharyngeal carcinoma (NPC) is rare, with a frequency below 1%. On this basis, a randomized trial demonstrated the oncological safety and improved quality of life after omission of radiotherapy (RT) to the MRLN in definitive chemoradiotherapy (CRT). Here, we evaluate the rate of MRLN involvement within a non-endemic cohort of NPC patients treated with RT/CRT in Germany.

MATERIAL/

METHODS

The MERLIN study (jARO-2025-05; DRKS00034782) is a retrospective multicenter study organized by the young DEGRO trial group. Patient inclusion required sufficient imaging and histologically proven NPC, treated with RT or CRT. Central review of cases, in which MRLN involvement was suspected, was performed by a board-certified radiologist and radiation oncologist.

RESULTS

We evaluated 305 patients from 9 centers treated between 2004 and 2023. Patients were treated with CRT (n = 277, 90.8%) or RT alone (n = 28, 9.1%). Neoadjuvant chemotherapy was applied in 18.2% (55/302) of patients. MRLN involvement was suspected in 21 cases. Central review confirmed MRLN involvement in nine patients, yielding a total rate of 2.95% (9/305) across all patients. In 70.2% (198/282) of patients, MRLN were included in the clinical target volume. Only one recurrence occurred in the medial retropharyngeal space, despite prior MRLN irradiation and no baseline MRLN involvement.

CONCLUSION

While involvement of MRLN was higher compared with cohorts from NPC-endemic regions, recurrence in MRLN was a rare event. After careful staging, omission of elective MRLN irradiation appears safe in NPC patients from non-endemic regions.

Для цитирования: Kaufmann Justus, Nikolaidou Eirini, Krabbes Isabel, Oji Nwabata, Ferdinandus Simone, Hlouschek Julian, Wurschi Georg, Becker Jan-Niklas, Schaule Jana, Müller Jörg-Andreas, Oebel Laura, Altmann Sebastian, Ehret Felix, Rühle Alexander, Grad Christian. Medial retropharyngeal lymph node involvement in nasopharyngeal cancer patients treated with radiotherapy in Germany - A multicenter analysis.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2026. DOI: 10.1016/j.radonc.2026.111696.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.